Idalbi Tablet 40 mg (Azilsartan Medoxomil Potassium)

Adult dosage

The recommended initial dose of this medication is 40 mg once daily, taken regardless of meals. If blood pressure is not adequately controlled, it can be increased up to a maximum of 80 mg daily.

Children's dosage

The safety and efficacy of this medication for children and adolescents under 18 years of age have not been established.

This medication can cause serious harm to the fetus or newborn if used by women in the second and third trimesters of pregnancy. Therefore, it should be discontinued immediately upon confirmation of pregnancy. It should not be used by individuals allergic to this medication or any of its ingredients, pregnant women, and patients with certain kidney diseases or diabetes. In patients with compromised cardiac function or severe renal impairment, or those with narrowed renal arteries, this medication should be used cautiously, and blood pressure and kidney function should be monitored frequently. Taking this medication with other antihypertensives may increase the risk of side effects such as hypotension, hyperkalemia, and decreased renal function, so co-administration should be avoided. Patients with reduced blood volume or low salt levels may experience hypotension at the outset of treatment, so their status needs to be carefully assessed before administration, and appropriate measures should be taken if necessary. Taking this medication alongside potassium-sparing diuretics or potassium supplements may dangerously elevate serum potassium levels, necessitating periodic monitoring of potassium levels. This medication may cause side effects such as dizziness, hypotension, nausea, rash, and fatigue, particularly in the elderly or patients with impaired renal function, where the likelihood of side effects is increased. Caution is advised when driving or operating machinery, as dizziness or drowsiness may occur. Patients taking lithium or nonsteroidal anti-inflammatory drugs (NSAIDs) should consult their doctor, as side effects or efficacy changes may occur. Pregnant or nursing women are advised to avoid using this medication, especially during breastfeeding, as the drug may be transmitted through breast milk and its safety has not been established. In case of overdose, hypotension and dizziness may occur, and medical attention should be sought immediately for appropriate treatment. This medication should be kept out of reach of children and stored in its original packaging away from light and moisture.

Serious side effects

• Hives
• angioedema
• hypotension
• fainting
• syncope
• dyspnea
• acute kidney injury
• acute renal failure
• headache
• subdural hematoma

Mild side effects

• Dizziness
• headache
• nasopharyngitis
• nausea
• diarrhea
• rash
• itching
• muscle cramps
• fatigue
• peripheral edema

This medication should be stored in a container that protects it from light and air, at a temperature between 1°C and 30°C. It is also important to avoid storing it in humid locations.

Appearance

White or nearly white round tablet

Package unit

PTP packaging: 14 tablets, 28 tablets, 30 tablets, 56 tablets, 90 tablets, 98 tablets per carton